DK1419177T3 - Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin - Google Patents

Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin

Info

Publication number
DK1419177T3
DK1419177T3 DK02754557T DK02754557T DK1419177T3 DK 1419177 T3 DK1419177 T3 DK 1419177T3 DK 02754557 T DK02754557 T DK 02754557T DK 02754557 T DK02754557 T DK 02754557T DK 1419177 T3 DK1419177 T3 DK 1419177T3
Authority
DK
Denmark
Prior art keywords
globulin
medicine
scale production
purification process
product
Prior art date
Application number
DK02754557T
Other languages
English (en)
Inventor
Inga Laursen
Gunnar Houen
Charlotte Svaerke Jorgensen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of DK1419177T3 publication Critical patent/DK1419177T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
DK02754557T 2001-08-14 2002-08-12 Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin DK1419177T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101217 2001-08-14
PCT/DK2002/000531 WO2003016348A2 (en) 2001-08-14 2002-08-12 A purification process for large scale production of gc-globulin, product obtained thereby and their use in medicine

Publications (1)

Publication Number Publication Date
DK1419177T3 true DK1419177T3 (da) 2008-08-25

Family

ID=8160667

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754557T DK1419177T3 (da) 2001-08-14 2002-08-12 Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin

Country Status (9)

Country Link
EP (1) EP1419177B1 (da)
JP (1) JP2005508892A (da)
AT (1) ATE393780T1 (da)
AU (1) AU2002321012B2 (da)
CA (1) CA2456843A1 (da)
DE (1) DE60226327T2 (da)
DK (1) DK1419177T3 (da)
ES (1) ES2305272T3 (da)
WO (1) WO2003016348A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005265960B8 (en) * 2004-06-29 2012-01-12 Reliance Life Sciences Pvt Ltd Process for improvement of virus-safe biological fluids
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
SG185601A1 (en) * 2010-05-18 2012-12-28 Abbvie Inc Apparatus and process of purification of proteins
EP2612921B1 (en) 2010-09-03 2016-11-02 Morita Pharmaceutical Ind., Ltd. Method for production of novel degalactosylated gc globulin
EP2682168A1 (en) 2012-07-02 2014-01-08 Millipore Corporation Purification of biological molecules
LT3081221T (lt) * 2013-12-13 2021-09-10 Saisei Pharma Co., Ltd. Farmacinė kompozicija, apimanti fermentu apdorotą galvijo priešpienį
WO2015158776A1 (en) * 2014-04-15 2015-10-22 Boehringer Ingelheim International Gmbh Methods, apparatuses, and systems for continuously inactivating a virus during manufacture of a biological product
WO2016194914A1 (ja) * 2015-06-01 2016-12-08 再生ファーマ株式会社 乳酵素処理物、その製造方法、組成物および製品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5177002A (en) * 1989-11-20 1993-01-05 Nobuto Yamamoto In vitro enzymatic conversion of glycosylated human vitamin D binding protein to a potent macrophage activating factor
DK0526544T3 (da) * 1990-04-11 1999-06-21 Brigham & Womens Hospital Terapeutiske anvendelser af actinbindende forbindelser
US6268478B1 (en) * 1996-02-12 2001-07-31 Cedars-Sinai Medical Center Intracellular vitamin D binding protein

Also Published As

Publication number Publication date
CA2456843A1 (en) 2003-02-27
DE60226327T2 (de) 2009-07-09
ES2305272T3 (es) 2008-11-01
EP1419177A2 (en) 2004-05-19
WO2003016348A3 (en) 2004-03-04
JP2005508892A (ja) 2005-04-07
ATE393780T1 (de) 2008-05-15
DE60226327D1 (de) 2008-06-12
EP1419177B1 (en) 2008-04-30
WO2003016348A2 (en) 2003-02-27
AU2002321012B2 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
DK1692516T3 (da) Terapifremgangsmåde
EP1728076A4 (en) SYSTEM AND METHOD FOR PROVIDING OPTIMUM CONCENTRATIONS FOR MEDICAMENT INFUSIONS
DK1419177T3 (da) Rensningsproces til fremstilling i stor skala af Gc-globulin og produkt tilvejebragt ved anvendelse af den samt deres anvendelse indenfor medicin
WO1995025171A3 (de) Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung
Husain et al. Translation, adaptation and validation of Depression, Anxiety and Stress Scale in Urdu
Chen et al. Adjustable parameters and the effectiveness of adjunct robot-assisted gait training in individuals with chronic stroke
CN104224863A (zh) 金钱草总黄酮在制备降低高尿酸血症药物中的应用
Lee et al. The effect of family support, self-efficacy, and fatigue on the quality of life in hemodialysis patients
NO20060637L (no) Autologe selv-toleranse induserende celler av monocytisk opprinnelse og deres anvendelse i farmasoytiske preparater
Zhang et al. Electroacupuncture promotes nerve regeneration and functional recovery in rats with spinal cord contusion through the coordinate interaction of CD4 and BDNF
CN108347886A (zh) 具降低疼痛功效的猴头萜、猴头菇菌丝体活性物质、其制备方法、及含其的医药组合物
CN103789291A (zh) 一种重组大肠杆菌发酵液中分离纯化重组人尿激酶原的制备工艺
Kim et al. An Analysis of Aconiti Ciliare Radix Patents
CN106279406A (zh) 猪皮中分离纯化的皮抑素g1的活性成分四连接素及其应用
Dai et al. Effect of Acupuncture on Serum SOD and MDA of Rats in Menopause
RU2489172C1 (ru) Способ проведения лечебного дискретного плазмафереза с экстракарпоральной модификацией эритроцитов и лейкоцитов индукторами интерферона, антиоксидантами и протекторами клеток
Cheng et al. A Novel pH Dependent C5 Monoclonal Antibody with Better Developability
Jabraeili et al. The Effects of Field massage on urine cortisol level in premature infants: clinical trial
Waller et al. Direct Oral Anticoagulants Reduce Hypercoagulopathy and Preserve Podocyte Function in an Experimental Model of Glomerular Disease
CN105998313A (zh) 一种彻底治疗心脑血管疾病的中药配方
Yan Effects of Mouse Nerve Growth Factor Combined with Donepezil in the Treatment of Alzheimer's Disease
Park et al. Two Case Reports of Leukocytoclastic Vasculitis after ChAdOxl nCoV-19 Vaccine
RU2115125C1 (ru) Способ защиты лимфоидных клеток крови человека от вич
Guida et al. ORCID ID 0000-0003-1027-7049. Genetic Polymorphism in Porphyria: Resolution of A Case of Tetraplegia by Administration of Hemin During a Porphyric Crisis and Subsequent Therapeutic Procedure with the use of Givosiran
Jamiu et al. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences